Literature DB >> 27918754

Interventions to Improve Rates of Successful Extubation in Preterm Infants: A Systematic Review and Meta-analysis.

Kristin N Ferguson1, Calum T Roberts2, Brett J Manley2, Peter G Davis3.   

Abstract

Importance: Clinicians aim to extubate preterm infants as early as possible, to minimize the risks of mechanical ventilation. Extubation is often unsuccessful owing to lung disease or inadequate respiratory drive. Objective: To conduct a systematic review and meta-analysis of interventions to improve rates of successful extubation in preterm infants. Data Sources: Searches were undertaken in PubMed and The Cochrane Library. Study Selection: The review was conducted using the methods of the Cochrane Collaboration and Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Studies were included if they were randomized clinical trials published in English, enrolled intubated preterm infants (born <37 weeks' gestation), and reported 1 or both of the primary outcomes. Data Extraction and Synthesis: One thousand three hundred seventy-nine titles were screened independently by 2 investigators to assess need for full-text review. Disagreements were resolved via consensus of all authors. Where no Cochrane Review existed for an intervention, or not all identified studies were included, a new pooled analysis was performed. Main Outcomes and Measures: Primary outcomes were treatment failure or reintubation within 7 days of extubation.
Results: Fifty studies were eligible for inclusion. Continuous positive airway pressure reduced extubation failure in comparison with head-box oxygen (risk ratio [RR], 0.59; 95% CI, 0.48-0.72; number needed to treat [NNT], 6; 95% CI, 3-9). Nasal intermittent positive pressure ventilation was superior to continuous positive airway pressure in preventing extubation failure (RR, 0.70; 95% CI, 0.60-0.81; NNT, 8; 95% CI, 5-13). High-flow nasal cannula therapy and continuous positive airway pressure had similar efficacy (RR, 1.11; 95% CI, 0.84-1.47). Methylxanthines reduced extubation failure (RR, 0.48; 95% CI, 0.32-0.71; NNT, 4; 95% CI, 2-7) compared with placebo or no treatment. Corticosteroids (RR, 0.18; 95% CI, 0.04-0.97; NNT, 12; 95% CI, 6-100) and chest physiotherapy (RR, 0.32; 95% CI, 0.13-0.82; NNT, 15; 95% CI, 7-50) both reduced extubation failure rates but were associated with significant adverse effects. Doxapram did not aid successful extubation (RR, 0.80; 95% CI, 0.22-2.97). Conclusions and Relevance: Preterm infants should be extubated to noninvasive respiratory support. Caffeine should be used routinely, while corticosteroids should be used judiciously, weighing up the competing risks of bronchopulmonary dysplasia and neurodevelopmental harm.

Entities:  

Mesh:

Year:  2017        PMID: 27918754     DOI: 10.1001/jamapediatrics.2016.3015

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN: 2168-6203            Impact factor:   16.193


  21 in total

Review 1.  [Research advances in the methods for weaning from high-frequency oscillatory ventilation in neonates].

Authors:  Ming-Yuan He; Xin-Zhu Lin
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2019-12

2.  Patterns of reintubation in extremely preterm infants: a longitudinal cohort study.

Authors:  Wissam Shalish; Lara Kanbar; Martin Keszler; Sanjay Chawla; Lajos Kovacs; Smita Rao; Bogdan A Panaitescu; Alyse Laliberte; Doina Precup; Karen Brown; Robert E Kearney; Guilherme M Sant'Anna
Journal:  Pediatr Res       Date:  2018-01-31       Impact factor: 3.756

3.  Markers of Successful Extubation in Extremely Preterm Infants, and Morbidity After Failed Extubation.

Authors:  Sanjay Chawla; Girija Natarajan; Seetha Shankaran; Benjamin Carper; Luc P Brion; Martin Keszler; Waldemar A Carlo; Namasivayam Ambalavanan; Marie G Gantz; Abhik Das; Neil Finer; Ronald N Goldberg; C Michael Cotten; Rosemary D Higgins
Journal:  J Pediatr       Date:  2017-06-07       Impact factor: 4.406

4.  [Clinical effect of an additional maintenance dose of caffeine before ventilator weaning in preterm infants with respiratory distress syndrome: a prospective randomized controlled trial].

Authors:  Ling-Song Yao; Xin-Zhu Lin; Jing Huang; Li-Xia Tang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2021-01

5.  Effect of High-Flow Nasal Cannula Therapy vs Continuous Positive Airway Pressure Following Extubation on Liberation From Respiratory Support in Critically Ill Children: A Randomized Clinical Trial.

Authors:  Padmanabhan Ramnarayan; Alvin Richards-Belle; Laura Drikite; Michelle Saull; Izabella Orzechowska; Robert Darnell; Zia Sadique; Julie Lester; Kevin P Morris; Lyvonne N Tume; Peter J Davis; Mark J Peters; Richard G Feltbower; Richard Grieve; Karen Thomas; Paul R Mouncey; David A Harrison; Kathryn M Rowan
Journal:  JAMA       Date:  2022-04-26       Impact factor: 157.335

Review 6.  Key paediatric messages from the 2017 European Respiratory Society International Congress.

Authors:  Jonathan Grigg; Jürg Barben; Mark L Everard; Graham Hall; Bülent Karadag; Alexander Moeller; Raffaella Nenna; Kostas N Priftis; Robbert J Rottier; Suzanne W J Terheggen-Lagro; Fabio Midulla
Journal:  ERJ Open Res       Date:  2018-05-25

7.  Feasibility of neurally synchronized and proportional negative pressure ventilation in a small animal model.

Authors:  Daijiro Takahashi; Ling Liu; Christer Sinderby; Jennifer Beck
Journal:  Physiol Rep       Date:  2020-07

Review 8.  Current insights in non-invasive ventilation for the treatment of neonatal respiratory disease.

Authors:  Dhivya Lakshmi Permall; Asfia Banu Pasha; Xiao-Qing Chen
Journal:  Ital J Pediatr       Date:  2019-08-19       Impact factor: 2.638

9.  Mechanisms of nasal high flow therapy in newborns.

Authors:  Pavel Mazmanyan; Mari Darakchyan; Maximilian I Pinkham; Stanislav Tatkov
Journal:  J Appl Physiol (1985)       Date:  2020-02-20

Review 10.  A Review on Non-invasive Respiratory Support for Management of Respiratory Distress in Extremely Preterm Infants.

Authors:  Yuan Shi; Hemananda Muniraman; Manoj Biniwale; Rangasamy Ramanathan
Journal:  Front Pediatr       Date:  2020-05-28       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.